Strengthening the oversight of breast implants / Sean Casey, chair. : XC62-1/1-441-16E-PDF

"Health Canada regulates breast implants as class IV medical devices, the category representing the highest risk. Breast implants are associated with a wide range of adverse effects, including a type of cancer of the immune system known as “breast implant-associated anaplastic large cell lymphoma.” For decades, the federal government has been called upon to make regulatory changes to enhance the safety of breast implants, yet important gaps remain in the oversight of these devices. Breast implant recipients continue to be insufficiently protected from adverse outcomes. The House of Commons Standing Committee on Health undertook a study to follow up on the improvements put in place as part of Health Canada’s 2018 action plan on medical devices, as well as to assess the feasibility of the creation of a central breast implant registry. The committee heard strong support from plastic surgeons, researchers and patient advocates for the creation of a national breast implant registry. Such a registry would improve the traceability of implants, facilitate recalls and advance research related to breast implants"--Summary.

Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.931082&sl=1

• Format MARC XML
• Format MARC HTML

Demander des formats alternatifs